Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide 2.4mg–7.2mg) is a prescription-only medicine licensed in the UK for weight management in adults with a BMI of 30 or above, or 27–29.9 alongside a weight-related health condition. That means any legitimate pharmacy supplying it — online or on the high street — must first obtain a valid prescription from a registered prescriber following a clinical assessment. Semaglutide's licensed place in UK weight management is well established, and the route to it is straightforward once you understand the legal and clinical steps involved.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE recommended semaglutide for weight management in March 2023 (Technology Appraisal TA875), but with a specific condition: it should be prescribed within a specialist weight management service, for a maximum of two years, in adults with a BMI of 35 or above and at least one weight-related comorbidity. Ethnic-background thresholds are typically 2.5 kg/m² lower. On the NHS, that usually means a referral and (in many parts of England) a significant wait.
Private prescriptions work differently. Any pharmacy holding a GPhC registration can dispense a lawfully issued private prescription for Wegovy, provided the prescriber has carried out a proper clinical assessment. The MHRA licenses Wegovy for adults with a BMI of 30 or above (or 27–29.9 with a weight-related condition), so private eligibility is broader than the NHS criteria. That gap is precisely why many people turn to a regulated online pharmacy for Wegovy rather than waiting for an NHS referral. Results from the STEP 1 trial (published in the New England Journal of Medicine) showed an average 15% reduction in body weight over 68 weeks at 2.4mg, which is the evidence base underpinning clinical enthusiasm for semaglutide.
The Wegovy 7.2mg dose, approved by the MHRA in April 2026 as a dedicated single-dose pen, is now part of the licensed UK schedule. Availability of specific doses and pen formats is confirmed at consultation rather than assumed, stock varies across pharmacies and changes as supply chains evolve.
A question our prescribers hear most weeks: "How do I know if the pharmacy I've found online is real?" The answer is one step, look it up on the GPhC pharmacy register. Every UK pharmacy legally dispensing prescription medicines must appear there. If a seller cannot be found on the register, that is a hard stop.
Beyond registration, the MHRA has issued repeated warnings about counterfeit semaglutide pens sold through social media and unofficial websites. Around 20 million doses of illegally traded weight-loss medicines (roughly £45m street value) were seized in 2025 alone, and enforcement has included the first UK raid on a site manufacturing fake tirzepatide pens. The pattern is consistent: prices that look implausibly low, sellers who do not ask any medical questions, and no verifiable pharmacy registration. Some fake pens have been found to contain insulin rather than semaglutide, a potentially life-threatening substitution.
Red flags to watch for include offers to supply the medicine without asking for a prescription or any clinical history, discount codes for prescription-only medicines, and sellers operating only through Instagram or WhatsApp. You can report a suspect seller directly to the MHRA at yellowcard.mhra.gov.uk. This is how the pharmacy for Wegovy you choose should be evaluated, by registration and clinical process, not by headline price.
NHS access to Wegovy sits within specialist services under TA875, and waiting lists in many areas run to months or longer. The criteria are also stricter than the licensed indication. For people who meet the private eligibility threshold but not the NHS one, or who simply cannot wait, a GPhC-registered pharmacy offering a private prescription is a lawful alternative.
Private pharmacies vary considerably in how they operate. Some require an in-person GP visit first; others, including fully digital services, carry out the clinical assessment remotely through a GPhC-registered Independent Prescriber. What should not vary is the fact of a prescriber reviewing your medical history before anything is dispensed. If a pharmacy skips that step, it is not operating legally, regardless of how it presents itself. For broader context on what private weight-loss treatment typically costs and what reputable providers include in their pricing, the weight-loss treatment overview is a useful starting point.
Storage is the same regardless of which pharmacy supplies the pen: refrigerated at 2–8°C, with a limited room-temperature window detailed in the Patient Information Leaflet. Injection sites are the abdomen, thigh or upper arm, rotated each week. These practicalities do not change between pharmacies, the clinical oversight around them should not either. If you have questions about side effects like sulfur burps on Wegovy, your prescribing pharmacy should be your first call.
The process at a properly regulated service follows a clear sequence. You complete a clinical questionnaire covering your BMI, medical history and current medicines. A GPhC-registered Independent Prescriber reviews that information (a real clinician, reading your answers) and either approves, requests more detail, or declines based on clinical grounds. If approved, a prescription is issued and the pharmacy dispenses against it.
At nume, the prescriber review happens the same day. Orders placed before 12pm on a working day are dispatched the same day once clinically approved, delivered the next working day by DPD in plain packaging. Aftercare is available seven days a week. There is no subscription: every repeat order is reviewed again before anything is sent. The factors that make a Wegovy pharmacy worth using go beyond convenience, they include how thoroughly the prescriber reviews your case and what happens if you have questions between doses.
For anyone exploring semaglutide more broadly, including how it compares to other licensed options, semaglutide dispensing in UK pharmacies covers the wider landscape. The process of obtaining Wegovy in the UK walks through eligibility and next steps in more detail. And if you want to understand how our clinical team approaches these decisions, our lead prescriber's profile is there to read. When you are ready, you can start your free consultation and have your case reviewed by a prescriber today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.